Nima Sharifi
Medical Oncology Branch
National Cancer Institute
Bethesda
Maryland 20892
USA
Name/email consistency: high
- Secondary hormonal therapy for prostate cancer: what lies on the horizon?. Sharifi, N., Dahut, W.L., Figg, W.D. BJU Int. (2008)
- Transforming growth factor-beta receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate? Sharifi, N., Lechleider, R.J., Farrar, W.L. J. Mol. Endocrinol. (2007)
- A bifunctional colchicinoid that binds to the androgen receptor. Sharifi, N., Hamel, E., Lill, M.A., Risbood, P., Kane, C.T., Hossain, M.T., Jones, A., Dalton, J.T., Farrar, W.L. Mol. Cancer Ther. (2007)
- Androgen receptor modulation: lessons learned from beyond the prostate. Sharifi, N., Figg, W.D. Cancer Biol. Ther. (2007)
- TGFBR3 loss and consequences in prostate cancer. Sharifi, N., Hurt, E.M., Kawasaki, B.T., Farrar, W.L. Prostate (2007)
- Perturbations in hypoxia detection: a shared link between hereditary and sporadic tumor formation?. Sharifi, N., Farrar, W.L. Med. Hypotheses (2006)
- Androgen receptor as a therapeutic target for androgen independent prostate cancer. Sharifi, N., Farrar, W.L. Am. J. Ther (2006)